Gilead Sciences, Inc. Faces Challenges For High Prices Of Sovaldi In Europe

February 10, 2015 10:07 AM

12 0

Gilead faces legal challenges in Europe by the Medecins du Monde over the exorbitant prices for Sovaldi

Gilead has been legally challenged by the European Medecins du Monde (MdM) for charging "exorbitant" prices for its Hepatitis C (HCV) treatment, Sovaldi.

Read more

To category page